GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
- Conditions
- Vomiting
- Interventions
- Drug: GW679769
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2017-09-25
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 24
- Registration Number
- NCT00359177
- Locations
- 🇺🇸
GSK Investigational Site, Orlando, Florida, United States
Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 28
- Registration Number
- NCT00359190
- Locations
- 🇮🇱
GSK Investigational Site, Zrifin, Israel
Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)
- Conditions
- Infections, Bacterial
- Interventions
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 24
- Registration Number
- NCT00358371
- Locations
- 🇩🇪
GSK Investigational Site, Greifswald, Mecklenburg-Vorpommern, Germany
Study Of Perennial Allergic Rhinitis
- Conditions
- Rhinitis, Allergic, Seasonal
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 65
- Registration Number
- NCT00358475
- Locations
GSK Investigational Site
Chronic Obstructive Pulmonary Disease Endpoints Study
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 163
- Registration Number
- NCT00358358
- Locations
- 🇷🇺
GSK Investigational Site, Nizhnekamsk, Russian Federation
Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 10
- Registration Number
- NCT00358384
- Locations
- 🇫🇷
GSK Investigational Site, Paris, France
Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 84
- Registration Number
- NCT00358449
- Locations
- 🇬🇧
GSK Investigational Site, Watford, United Kingdom
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 54
- Registration Number
- NCT00358488
- Locations
- 🇬🇧
GSK Investigational Site, Manchester, United Kingdom
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
- Conditions
- Nonulcer Dyspepsia
- Interventions
- Drug: PlaceboDrug: GW679769 oral tablets
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 13
- Registration Number
- NCT00358410
- Locations
- 🇧🇪
GSK Investigational Site, Leuven, Belgium
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
- Conditions
- Restless Legs SyndromeModerate to Severe Idiopathic Restless Legs Syndrome (RLS)
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2012-06-07
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 240
- Registration Number
- NCT00357097
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany